ASSESSMENT OF POTENTIAL COCAINE TREATMENT MEDICATIONS
潜在可卡因治疗药物的评估
基本信息
- 批准号:6358366
- 负责人:
- 金额:$ 19.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 2001-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This represents a competitive renewal of NIDA contract N01DA29305,
entitled "Assessment of Potential Cocaine Treatment Medications in
Rodents". The objectives of this research and development contract is
to determine the effects of compounds in the rodent locomotor activity
and drug discrimination procedures as a means of evaluating their
potential efficacy as cocaine treatment medications. These tests have
been selected by NIDA Medication Development Division's (MDD)
Cocaine Treatment Discovery Program (CTDP) because they are
believed to represent model systems that may be predictive of clinical
efficacy of pharmacotherapies for cocaine dependence. The data
generated by this contract will be utilized by the NIDA/MDD/CTDP in
the selection of compounds for additional preclinical evaluation and
subsequent development as pharmacotherapies for cocaine
dependence. Briefly, the Contractor will be screening compounds in
the mouse locomotor activity and rat drug discrimination test. We
respect to the locomotor activity procedure, the effect of the
compound, administered alone and in combination with cocaine, on
locomotor activity in mice will be assessed. Depending on results
obtained from the locomotor activity test, the compound will either be
evaluated for the ability to antagonize the discriminative (subjective)
effects of cocaine or to substitute for the discriminative (subjective)
effects of cocaine. The anticipated end results of this contract will be
written reports detailing study findings.
这是NIDA合同N01DA29305的竞争性续签。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.
单胺氧化酶抑制剂对大鼠可卡因辨别的影响。
- DOI:10.1097/01.fbp.0000197459.08892.b5
- 发表时间:2006
- 期刊:
- 影响因子:1.6
- 作者:Gatch,MichaelB;Taylor,CynthiaM;Flores,Elva;Selvig,Meghan;Forster,MichaelJ
- 通讯作者:Forster,MichaelJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J. FORSTER其他文献
MICHAEL J. FORSTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J. FORSTER', 18)}}的其他基金
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
9021008 - 财政年份:2013
- 资助金额:
$ 19.16万 - 项目类别:
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
8620729 - 财政年份:2013
- 资助金额:
$ 19.16万 - 项目类别:
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
8506257 - 财政年份:2013
- 资助金额:
$ 19.16万 - 项目类别:
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
9240669 - 财政年份:2013
- 资助金额:
$ 19.16万 - 项目类别:
相似国自然基金
抗可卡因(Cocaine)抗体酶的研制及实验研究
- 批准号:39570633
- 批准年份:1995
- 资助金额:8.5 万元
- 项目类别:面上项目
相似海外基金
Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine Users
研究导致可卡因吸食者中艾滋病毒持续存在的宿主基因亚型
- 批准号:
10788990 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
The role of nucleus accumbens dopamine in incubation of cocaine craving
伏隔核多巴胺在可卡因渴望孵化中的作用
- 批准号:
10676025 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Repurposing Metformin as a Treatment for Cocaine Use Disorder
重新利用二甲双胍治疗可卡因使用障碍
- 批准号:
10823844 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Modeling cue-triggered relapse to cocaine use in rats
模拟提示触发大鼠可卡因吸毒复发
- 批准号:
479766 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Operating Grants
Hippocampal mechanisms of cocaine-memory reconsolidation
可卡因记忆重建的海马机制
- 批准号:
10736775 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Nucleus accumbens cholinergic interneurons and cue-induced cocaine craving
伏核胆碱能中间神经元和提示诱导的可卡因渴望
- 批准号:
10738973 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939
任务单 01 可卡因相互作用在大鼠中的安全性研究。
- 批准号:
10947939 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Endocannabinoid regulation of the corticoaccumbens pathway and stress-enhanced cocaine-seeking behavior
内源性大麻素对伏隔皮质通路的调节和压力增强的可卡因寻求行为
- 批准号:
10750394 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Targeting Phospholipase C and Dendritic Spines to Reduce Cocaine and Heroin Motivation
靶向磷脂酶 C 和树突棘以减少可卡因和海洛因动机
- 批准号:
10929771 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
使用 Cav3 通道和可溶性环氧化物水解酶的 IND 双重抑制剂开发可卡因使用障碍的新型治疗方法
- 批准号:
10786151 - 财政年份:2023
- 资助金额:
$ 19.16万 - 项目类别:














{{item.name}}会员




